• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经退行性疾病中的 HFE 突变作为一种应激反应模型。

HFE Mutations in Neurodegenerative Disease as a Model of Hormesis.

机构信息

Department of Neurosurgery, College of Medicine, The Pennsylvania State University, 700 HMC Crescent Road, Hershey, PA 17033, USA.

出版信息

Int J Mol Sci. 2024 Mar 15;25(6):3334. doi: 10.3390/ijms25063334.

DOI:10.3390/ijms25063334
PMID:38542306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10970347/
Abstract

Common variants in the iron regulatory protein HFE contribute to systematically increased iron levels, yet the effects in the brain are not fully characterized. It is commonly believed that iron dysregulation is a key contributor to neurodegenerative disease due to iron's ability to catalyze reactive oxygen species production. However, whether HFE variants exacerbate or protect against neurodegeneration has been heavily debated. Some claim that mutated HFE exacerbates oxidative stress and neuroinflammation, thus predisposing carriers to neurodegeneration-linked pathologies. However, H63D HFE has also been shown to slow the progression of multiple neurodegenerative diseases and to protect against environmental toxins that cause neurodegeneration. These conflicting results showcase the need to further understand the contribution of HFE variants to neurodegenerative disease heterogeneity. Data from mouse models consistently demonstrate robust neuroprotection against toxins known to increase the risk of neurodegenerative disease. This may represent an adaptive, or hormetic, response to increased iron, which leaves cells better protected against future stressors. This review describes the current research regarding the contribution of HFE variants to neurodegenerative disease prognosis in the context of a hormetic model. To our knowledge, this is the first time that a hormetic model for neurodegenerative disease has been presented.

摘要

常见的铁调节蛋白 HFE 变体导致铁水平系统升高,但铁在大脑中的作用尚未完全阐明。人们普遍认为,铁失调是神经退行性疾病的一个关键因素,因为铁能够催化活性氧物质的产生。然而,HFE 变体是否会加剧或预防神经退行性变一直存在很大争议。一些人声称,突变的 HFE 会加剧氧化应激和神经炎症,从而使携带者易患与神经退行性变相关的病变。然而,H63D HFE 也被证明可以减缓多种神经退行性疾病的进展,并预防导致神经退行性变的环境毒素。这些相互矛盾的结果表明,需要进一步了解 HFE 变体对神经退行性疾病异质性的贡献。来自小鼠模型的数据一致表明,对已知增加神经退行性疾病风险的毒素具有强大的神经保护作用。这可能代表了对铁增加的适应性或应激反应,使细胞对未来的应激源有更好的保护。本综述描述了当前关于 HFE 变体在神经退行性疾病预后中的作用的研究,其背景是应激模型。据我们所知,这是首次提出神经退行性疾病的应激模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe9/10970347/4d3c521ff259/ijms-25-03334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe9/10970347/c569e2f80d3d/ijms-25-03334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe9/10970347/4d3c521ff259/ijms-25-03334-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe9/10970347/c569e2f80d3d/ijms-25-03334-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbe9/10970347/4d3c521ff259/ijms-25-03334-g002.jpg

相似文献

1
HFE Mutations in Neurodegenerative Disease as a Model of Hormesis.神经退行性疾病中的 HFE 突变作为一种应激反应模型。
Int J Mol Sci. 2024 Mar 15;25(6):3334. doi: 10.3390/ijms25063334.
2
HFE gene variants affect iron in the brain.HFE 基因突变影响大脑中的铁。
J Nutr. 2011 Apr 1;141(4):729S-739S. doi: 10.3945/jn.110.130351. Epub 2011 Feb 23.
3
A mutation in the HFE gene is associated with altered brain iron profiles and increased oxidative stress in mice.HFE基因的突变与小鼠大脑铁分布改变及氧化应激增加有关。
Biochim Biophys Acta. 2013 Jun;1832(6):729-41. doi: 10.1016/j.bbadis.2013.02.009. Epub 2013 Feb 18.
4
A common variant in the iron regulatory gene (Hfe) alters the metabolic and transcriptional landscape in brain regions vulnerable to neurodegeneration.铁调节基因(Hfe)中的一种常见变异改变了易发生神经退行性变的脑区的代谢和转录格局。
J Neurochem. 2024 Sep;168(9):3132-3153. doi: 10.1111/jnc.16171. Epub 2024 Jul 29.
5
HFE mutations and Alzheimer's disease.遗传性血色素沉着症基因(HFE)突变与阿尔茨海默病
J Alzheimers Dis. 2006 Nov;10(2-3):267-76. doi: 10.3233/jad-2006-102-311.
6
HFE gene mutations in a population of Italian Parkinson's disease patients.意大利帕金森病患者群体中的HFE基因突变
Parkinsonism Relat Disord. 2008;14(5):426-30. doi: 10.1016/j.parkreldis.2007.10.011. Epub 2008 Mar 5.
7
Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.突变型 HFE H63D 蛋白与内质网应激延长和神经元易损性增加有关。
J Biol Chem. 2011 Apr 15;286(15):13161-70. doi: 10.1074/jbc.M110.170944. Epub 2011 Feb 24.
8
H63D HFE genotype accelerates disease progression in animal models of amyotrophic lateral sclerosis.H63D HFE基因分型会加速肌萎缩侧索硬化症动物模型中的疾病进展。
Biochim Biophys Acta. 2014 Dec;1842(12 Pt A):2413-26. doi: 10.1016/j.bbadis.2014.09.016. Epub 2014 Oct 5.
9
Association of HFE mutations with neurodegeneration and oxidative stress in Alzheimer's disease and correlation with APOE.HFE基因突变与阿尔茨海默病中的神经退行性变和氧化应激的关联以及与APOE的相关性
Am J Med Genet B Neuropsychiatr Genet. 2003 May 15;119B(1):48-53. doi: 10.1002/ajmg.b.10069.
10
H63D mutation in hemochromatosis alters cholesterol metabolism and induces memory impairment.血色素沉着症中的H63D突变会改变胆固醇代谢并导致记忆障碍。
Neurobiol Aging. 2014 Jun;35(6):1511.e1-12. doi: 10.1016/j.neurobiolaging.2013.12.014. Epub 2013 Dec 25.

引用本文的文献

1
Next Generation Sequencing Analysis in Patients Affected by Parkinson's Disease and Correlation Between Genotype and Phenotype in Selected Clinical Cases.帕金森病患者的下一代测序分析及部分临床病例的基因型与表型相关性研究
Int J Mol Sci. 2025 Mar 7;26(6):2397. doi: 10.3390/ijms26062397.
2
Human Leukocyte Antigen and microRNAs as Key Orchestrators of Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.人类白细胞抗原和 microRNAs 作为轻度认知障碍和阿尔茨海默病的关键协调因子:系统评价。
Int J Mol Sci. 2024 Aug 5;25(15):8544. doi: 10.3390/ijms25158544.
3
Investigating hormesis, aging, and neurodegeneration: From bench to clinics.

本文引用的文献

1
The p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with Mutations.p.H63D(p.His63Asp)多态性是意大利和法国突变型肌萎缩侧索硬化症患者疾病转归的一个修饰因素。
Biomedicines. 2023 Feb 24;11(3):704. doi: 10.3390/biomedicines11030704.
2
Quantitative and causal analysis for inflammatory genes and the risk of Parkinson's disease.炎症基因与帕金森病风险的定量和因果分析。
Front Immunol. 2023 Feb 28;14:1119315. doi: 10.3389/fimmu.2023.1119315. eCollection 2023.
3
Contributions of HFE polymorphisms to brain and blood iron load, and their links to cognitive and motor function in healthy adults.
探究毒物兴奋效应、衰老与神经退行性变:从实验室到临床
Open Med (Wars). 2024 Jun 17;19(1):20240986. doi: 10.1515/med-2024-0986. eCollection 2024.
载脂蛋白 E 基因多态性与脑铁和血铁负荷的关系及其对健康成年人认知和运动功能的影响。
Neuropsychopharmacol Rep. 2021 Sep;41(3):393-404. doi: 10.1002/npr2.12197. Epub 2021 Jul 21.
4
Common and rare variants in HFE are not associated with Parkinson's disease in Europeans.常见和罕见的 HFE 变异与欧洲人群的帕金森病无关。
Neurobiol Aging. 2021 Nov;107:174-177. doi: 10.1016/j.neurobiolaging.2021.05.019. Epub 2021 Jun 8.
5
HFE H63D Limits Nigral Vulnerability to Paraquat in Agricultural Workers.载脂蛋白 H63D 限制农业工人中百草枯引起的黑质易损性。
Toxicol Sci. 2021 Apr 27;181(1):47-57. doi: 10.1093/toxsci/kfab020.
6
HFE Genotype and Endurance Performance in Competitive Male Athletes.载脂蛋白 E 基因型与竞技男性运动员的耐力表现。
Med Sci Sports Exerc. 2021 Jul 1;53(7):1385-1390. doi: 10.1249/MSS.0000000000002595.
7
Hemochromatosis Mutations, Brain Iron Imaging, and Dementia in the UK Biobank Cohort.英国生物库队列中的血色病突变、脑铁成像和痴呆症。
J Alzheimers Dis. 2021;79(3):1203-1211. doi: 10.3233/JAD-201080.
8
Age-Related Changes and Sex-Related Differences in Brain Iron Metabolism.脑铁代谢的年龄相关性变化和性别相关性差异。
Nutrients. 2020 Aug 27;12(9):2601. doi: 10.3390/nu12092601.
9
Activation of transcription factor Nrf2 to counteract mitochondrial dysfunction in Parkinson's disease.激活转录因子 Nrf2 以对抗帕金森病中的线粒体功能障碍。
Med Res Rev. 2021 Mar;41(2):785-802. doi: 10.1002/med.21714. Epub 2020 Jul 18.
10
The roles of iron and HFE genotype in neurological diseases.铁和HFE基因分型在神经疾病中的作用。
Mol Aspects Med. 2020 Oct;75:100867. doi: 10.1016/j.mam.2020.100867. Epub 2020 Jul 9.